GENETIC REGULATION OF 03-INDUCED INFLAMMATION

03 引起的炎症的基因调控

基本信息

  • 批准号:
    6537597
  • 负责人:
  • 金额:
    $ 37.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-04-01 至 2004-03-31
  • 项目状态:
    已结题

项目摘要

Laboratory studies have demonstrated that short-term single exposure of adult humans to ambient levels of O3 leads to inflammation of the airway. Lung inflammation is observable 3-18 hr after exposure, and is not correlated to the functional changes that arise during exposures or slowly dissipate during recovery, 1-2 hr post-exposure. The inflammation is characterized by an influx of polymorphonuclear leukocytes and increases in total protein, albumin, pro-inflammatory cytokines, and granulocyte-macrophage colony-stimulating factor in bronchoalveolar lavage fluid. Significant inter-individual variation in the inflammatory response is found among otherwise homogeneous subjects suggesting that intrinsic host factors contribute to the magnitude of beta3-induced lung injury. Further, although ambient exposure to beta3 is frequently intermittent, whether the severity of inflammation increases upon re-exposure remains controversial. Thus, basic questions remain: 1) is the inter-individual nature of the inflammatory response to O3 explained by host factors, i.e., genetic background, and 2) do inflammatory airway responses in sensitive subjects adapt upon re-exposure to O3? Understanding the mechanisms intrinsic to O3-induced airway inflammation is essential for predicting host susceptibility and risk of lung and epithelial injury from exposure to O3. Our HYPOTHESIS is that specific gene polymorphisms/mutations contribute to differential susceptibility to O3-induced lung injury in healthy subjects and are host factors that regulate risk of exposure to O3. We will use a multi-disciplinary approach that applies physiologic and genetic techniques to a controlled human exposure system. Specific aims will determine: 1) the range in susceptibility of humans to develop airway inflammation and hyperpermeability after a single exposure to O3, and 2) if subjects differentially susceptible to ozone maintain their sensitivity during intermittent exposure to O3, and 3) the association of selected genetic markers with O3-induced lung injury and airway inflammatory responses. These investigations will help to establish genetic background as a host factor in the susceptibility of humans to O3 exposure and utility of genetic factors as biomarkers of lung injury induced by inhalable oxidants and environmental pollutants.
实验室研究表明,成年人短期单次暴露于环境水平的O3会导致气道炎症。 在暴露后3-18小时可观察到肺部炎症,与暴露期间出现的功能变化或暴露后1-2小时恢复期间缓慢消失的功能变化无关。 炎症的特征是多形核白细胞的流入和支气管肺泡灌洗液中总蛋白、白蛋白、促炎细胞因子和粒细胞-巨噬细胞集落刺激因子的增加。在其他同质受试者中发现炎症反应的显著个体间差异,表明内在宿主因素有助于β 3诱导的肺损伤的程度。 此外,尽管环境暴露于β 3通常是间歇性的,但再次暴露后炎症的严重程度是否会增加仍然存在争议。因此,基本问题仍然存在:1)对O3的炎症反应的个体间性质是否由宿主因素解释,即,遗传背景,和2)是否炎症气道反应在敏感的科目适应后重新暴露于O3?了解O3诱导的气道炎症的内在机制对于预测宿主易感性以及暴露于O3引起的肺和上皮损伤的风险至关重要。我们的假设是,特定的基因多态性/突变导致健康受试者对O3诱导的肺损伤的不同易感性,并且是调节O3暴露风险的宿主因素。 我们将采用多学科方法,将生理学和遗传学技术应用于受控的人体暴露系统。 具体目标将决定:1)人类在单次暴露于O3后发生气道炎症和高通透性的易感性范围,2)如果受试者对臭氧的敏感性差异在间歇暴露于O3期间保持其敏感性,3)选定的遗传标记与O3诱导的肺损伤和气道炎症反应的关联。 这些调查将有助于建立遗传背景作为一个主机因素的易感性,人类O3暴露和效用的遗传因素作为生物标志物的肺损伤引起的可吸入氧化剂和环境污染物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

W Michael Foster其他文献

W Michael Foster的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('W Michael Foster', 18)}}的其他基金

The Duke Multidisciplinary Training Program in Pediatric Lung Disease
杜克小儿肺部疾病多学科培训项目
  • 批准号:
    8499396
  • 财政年份:
    2010
  • 资助金额:
    $ 37.49万
  • 项目类别:
The Duke Multidisciplinary Training Program in Pediatric Lung Disease
杜克小儿肺部疾病多学科培训项目
  • 批准号:
    8312575
  • 财政年份:
    2010
  • 资助金额:
    $ 37.49万
  • 项目类别:
Surfactant Protein A Modulates Airway Response to Ozone in Human Asthma
表面活性剂蛋白 A 调节人类哮喘气道对臭氧的反应
  • 批准号:
    8325218
  • 财政年份:
    2009
  • 资助金额:
    $ 37.49万
  • 项目类别:
Functional implications of the TNF
TNF 的功能意义
  • 批准号:
    7536273
  • 财政年份:
    2008
  • 资助金额:
    $ 37.49万
  • 项目类别:
Dependency of O-3 Induced Lung Mucus Hypersecretion on NQ01
O-3 诱导的肺粘液分泌过多对 NQ01 的依赖性
  • 批准号:
    7678999
  • 财政年份:
    2008
  • 资助金额:
    $ 37.49万
  • 项目类别:
Dependency of O-3 Induced Lung Mucus Hypersecretion on NQ01
O-3 诱导的肺粘液分泌过多对 NQ01 的依赖性
  • 批准号:
    7532856
  • 财政年份:
    2008
  • 资助金额:
    $ 37.49万
  • 项目类别:
Functional implications of the TNF
TNF 的功能意义
  • 批准号:
    7683994
  • 财政年份:
    2008
  • 资助金额:
    $ 37.49万
  • 项目类别:
Facilities Core 3: Inhalation Toxicology
设施核心 3:吸入毒理学
  • 批准号:
    6741125
  • 财政年份:
    2004
  • 资助金额:
    $ 37.49万
  • 项目类别:
GENETIC REGULATION OF 03-INDUCED INFLAMMATION
03 引起的炎症的基因调控
  • 批准号:
    6413558
  • 财政年份:
    2000
  • 资助金额:
    $ 37.49万
  • 项目类别:
GENETIC REGULATION OF 03-INDUCED INFLAMMATION
03 引起的炎症的基因调控
  • 批准号:
    6390370
  • 财政年份:
    2000
  • 资助金额:
    $ 37.49万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.49万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 37.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了